← Evidence map

ReviewDrug design, development and therapy2023

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions.

Tiffany Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37064432